Its compounding-pathway status shifted in April 2026 when the FDA removed it from Category 2 of the 503A bulk substances list, though this is a compounding determination, not an approval
Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohn's disease: good safety profile but lack of efficacy
Megaloblastic anemia of the pernicious variety is brought on by a deficiency in the intrinsic factor, which prevents the absorption of vitamin B12
National Health and Medical Research Council
In this review, we summarized the recent approaches in OA treatment and the role of natural products, dietary supplements and nanogold application in OA treatment to provide new research tracks for more therapeutic opportunities to those who are in care in this field
While the pink or red color is expected when B12 is present, appearance is not a reliable indicator of quality or content